Subcutaneous electrode and lead with phoresis based pharmacological agent delivery
First Claim
1. An implantable cardiac lead, comprising:
- a lead body;
an electrode supported by the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient; and
a driving arrangement coupled to the lead, the driving arrangement configured to provide phoresis delivery of a pharmacological agent from the lead to subcutaneous tissue.
1 Assignment
0 Petitions
Accused Products
Abstract
An implantable subcutaneous device includes a lead and electrode for cardiac monitoring and intervention. The device has an implantable lead including a lead body, a subcutaneous electrode supported by the lead body and a pharmacological agent impelled from the device using phoresis. The pharmacological agent provides a therapeutic treatment to subcutaneous non-intrathoracic tissue. A method of implanting subcutaneous leads involves providing a lead including a lead body, a subcutaneous electrode, and a pharmacological agent and using phoresis to impel the pharmacological agent into subcutaneous non-intrathoracic tissue surrounding the lead.
117 Citations
66 Claims
-
1. An implantable cardiac lead, comprising:
-
a lead body;
an electrode supported by the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient; and
a driving arrangement coupled to the lead, the driving arrangement configured to provide phoresis delivery of a pharmacological agent from the lead to subcutaneous tissue. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
-
-
18. An implantable system, comprising:
-
a lead, comprising;
a lead body; and
an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient; and
a can coupled to the lead, the can configured to provide phoresis delivery of a pharmacological agent from at least a portion of the can to subcutaneous tissue. - View Dependent Claims (19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)
-
-
33. A method of lead implantation, comprising:
-
delivering a lead into subcutaneous non-intrathoracic tissue of a patient, the lead comprising a lead body, an electrode, and a pharmacological agent on the lead; and
impelling, using phoresis, the pharmacological agent from at least a portion of the lead to the subcutaneous non-intrathoracic tissue. - View Dependent Claims (34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47)
-
-
48. An implantable cardiac lead, comprising:
-
a lead body;
an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement in a patient; and
means, coupled to the implantable lead, for impelling a pharmacological agent using phoresis into subcutaneous non-intrathoracic tissue. - View Dependent Claims (49, 50, 51, 52, 53, 54)
-
-
55. A system, comprising:
-
an implantable medical device, comprising;
a can that houses circuitry configured to provide one or both of cardiac monitoring and cardiac stimulation; and
a lead coupled to the can, the lead comprising a lead body and an electrode coupled to the lead body, the electrode configured for subcutaneous non-intrathoracic placement within a patient; and
a driver apparatus detachably coupled to the implantable medical device, the driver apparatus configured to facilitate phoresis delivery of a pharmacological agent from one or both of the can and the lead. - View Dependent Claims (56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)
-
Specification